JCB logo
PeproTech: Cell Culture Supplements
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 21 March 2005. doi:10.1083/jcb1687iti4
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 168, Number 7, 985-985
This Article
Right arrow Full Text (PDF, 655K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

FGF gets in your bones



Sox2 prevents the differentiation of osteoblasts at the osteogenic front (of).

Wnt-mediated differentiation of bone precursors gets shut down, say Mansukhani et al. on page 1065, if there is too much FGF receptor (FGFR) activity.Bones form through the maturation of osteoblasts. This process is disrupted in the skulls of patients with activating mutations in FGFR1 and FGFR2. The new evidence suggests that FGF counteracts differentiation by blocking Wnt. Microarray analysis revealed that, although Wnt-regulated genes are normally turned on in maturing osteoblasts, their activation is dampened in the overactive FGFR mutant osteoblasts.

A major mediator of the FGF-induced Wnt down-regulation seems to be the Sox2 transcription factor. Normally associated with neurons or embryonic stem cells, Sox2 is now shown to be strongly expressed in osteoblasts when FGF signaling is high. Sox2 was associated with ß-catenin in osteoblasts and blocked Wnt signaling, possibly by competing with other ß-catenin partners, such as TCF/LEF transcriptional coactivators.

Wnt signals are used in multiple differentiation pathways, including several that are not blocked by FGF. Perhaps Sox2 is permanently silenced in the unaffected cell types. It will now be important to examine FGF and Sox2 regulation in normal and pathological skull development. Sox2 was found at osteogenic fronts in mice crania, where FGFR2 activity is known to be high, and may act as a brake on osteoblast differentiation. Harmonious bone formation, like other developmental processes, probably results from the interplay between positive and negative signals. {iti_end}



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation
Alka Mansukhani, Davide Ambrosetti, Greg Holmes, Lizbeth Cornivelli, and Claudio Basilico
J. Cell Biol. 2005 168: 1065-1076. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 655K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents